Advanced Radiotherapy Treatments Planned Using Varian’s RapidPlan Commence in Australia

On July 15, 2015 Varian Medical Systems reported a 71-year-old prostate cancer patient has become the first patient in Australia to receive radiotherapy treatments using RapidPlan knowledge-based planning from Varian Medical Systems (NYSE: VAR) (Press release, InfiMed, JUL 15, 2015, View Source [SID:1234506338]). The pioneering treatment was carried out at Radiation Oncology Queensland (ROQ) in Cairns.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"The treatment was planned both conventionally and using RapidPlan and we were comfortable that for this case RapidPlan produced a better treatment plan," says Kenton Thompson, ROQ’s head of radiation therapy services. "Using this approach, we are able to produce the same quality in a fraction of the time it takes to plan conventionally. The objective is to produce optimal plans with the best trade-off between sparing the organs at risk and covering the target and this is where knowledge-based planning can really help. RapidPlan helps to ensure that all plans are of the same high quality."

RapidPlan is a comprehensive tool within Varian’s Eclipse treatment planning system that may be used to plan all types of advanced radiotherapy techniques including intensity-modulated radiotherapy (IMRT), RapidArc radiotherapy, and stereotactic ablative radiotherapy (SABR). It enables users to draw from a library of ‘best-case’ plans to speed up the often time-consuming planning process and to optimize quality. In this way, such knowledge-based planning can allow future patients to benefit from the knowledge gained from past patients. In this case, clinicians at ROQ selected a prostate treatment model developed by Washington University in St. Louis.

"Historically, assessing plan quality has been more of a subjective process dependent on the skills and experience of the reviewer," said chief radiation therapist Mark Jones. "We want consistency across our sites and RapidPlan enables us to implement the same quality to benefit all of our patients. Through auditing and benchmarking, RapidPlan can be utilized as part of a continuing quality assurance program for treatment planning."

Since the first treatment, a second patient at Cairns has already commenced treatments after being planned with RapidPlan, and a similar approach is now being introduced at a second ROQ site in Toowoomba. Treatments at these ROQ hospitals are delivered using Varian linear accelerators.

"We are pleased to see such an eminent oncology center as ROQ introducing RapidPlan into the clinical workflow," said Stuart Hamilton, Varian’s regional sales director. "RapidPlan does for radiotherapy planning what our RapidArc system did for radiotherapy treatments by enhancing the speed, quality and accessibility of advanced treatments."